Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2018 10:04 ET | Source: Gradalis, Inc.

Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group

DALLAS, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications,...
August 28, 2018 19:16 ET | Source: Gradalis, Inc.

Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma

– The open-label trial will measure progression free survival of participants from date of randomization until first disease progression in the study – – The trial will use product produced from...